Report of Foreign Issuer (6-k)
November 07 2019 - 5:12PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of
Foreign Private Issuer
Pursuant to Rule 13a-16 or
15d-16 of
the Securities Exchange Act of 1934
For the month of November, 2019
Commission File Number: 001-36619
Affimed N.V.
Im
Neuenheimer Feld 582,
69120 Heidelberg,
Germany
(Address of
principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form
20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if
the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Affimed N.V. (Affimed or the Company) today issued three press releases. Copies of
each of the Companys press releases are filed as Exhibit 99.1, Exhibit 99.2 and Exhibit 99.3 to this Report on Form 6-K, and are incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized, in Heidelberg, Germany,
November 7, 2019.
|
|
|
AFFIMED N.V.
|
|
|
By:
|
|
/s/ Adi Hoess
|
|
|
Name: Adi Hoess
|
|
|
Title: Chief Executive Officer
|
|
|
By:
|
|
/s/ Florian Fischer
|
|
|
Name: Florian Fischer
|
|
|
Title: Chief Financial Officer
|
EXHIBIT INDEX
|
|
|
Exhibit
|
|
Description of Exhibit
|
|
|
99.1
|
|
Affimed N.V. Press Release Affimed Announces Proposed Public Offering of Common Shares, dated November 7, 2019
|
|
|
99.2
|
|
Affimed N.V. Press Release Affimed Highlights Progress on NK Cell Engager Collaboration with Genentech dated November 7, 2019
|
|
|
99.3
|
|
Affimed N.V. Press Release Affimed Announces FDA Clearance of IND to Commence First-in-Human Phase 1/2a Study of AFM24 for the Treatment of
EGFR-Expressing Cancers, dated November 7, 2019
|
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Apr 2023 to Apr 2024